Hints and tips:
Related Special Reports
...SoftBank founder predicts WeWork V for Victory Masayoshi Son admitted today he had turned a “blind eye” to governance lapses at WeWork but promised a “sharp V-shaped recovery” for the shared offices provider...
...She cleaned the general office space, rather than the laboratories, according to her sworn declaration filed in the case....
...One of his touchstones for anti-competitive behaviour is the late 1990s US v Microsoft case, in which the company was found guilty of using its operating system monopoly to stifle competitors like Netscape...
...Qubits v bytes: how quantum computing works Quantum computing taps into the quirky behaviour of sub-atomic particles, which bend our normal understanding of physics....
...He places human embryonic and pluripotent stem cells — that have the potential to grow into nearly every cell of the body — in tiny ‘U’ or ‘V’ shaped dishes in the lab to grow them into different types of...
...Will a move from the laboratory bench to the boardroom table improve returns for shareholders?...
...Thanks to a series of court rulings since the mid-2000s, such as eBay v MercExchange in 2007, Mayo Collaborative Services v Prometheus Laboratories in 2012 and Alice Corp v CLS Bank in 2014, and the subsequent...
...Mr Saunders says that, in buying Whole Foods, Amazon is also acquiring a larger laboratory for its experiments in bricks-and-mortar retailing, which have multiplied over the past two years — but only on...
...their way out of the laboratory into run-of-the-mill reality....
...Such bets are not always doomed: Novartis did well by buying Alcon eyecare from Nestlé on a 23 times forward multiple. But investors should pause for thought....
...“You buy drugs from a pharmacy website showing a picture of a respectable doctor in a white coat in a laboratory, but the reality is you are getting them from someone selling them out of a box in his living...
...prescription medicines, notably for cancer, spurning a broader trend for diversification championed by others including Pfizer, Merck and its Basel neighbour Novartis, which paid $28bn for the eyecare business Alcon...
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...Novartis has moved into eyecare products with its acquisition of Alcon; GSK has strengthened its position in consumer healthcare by purchasing Stiefel for dermatology; and Sanofi-Aventis and Merck have invested...
...A $50bn transatlantic healthcare deal between Novatis and Alcon cheered investor sentiment while the latest surveys of global manufacturing highlighted a further rebound in activity....
...Novartis is to complete its $50bn purchase of Alcon, the US eyecare company, this year. Sanofi-Aventis hopes to renew its animal health joint venture with Merck in an enlarged joint venture....
...GlaxoSmithKline, the pharmaceutical group, has agreed to pay up to $3.6bn (£2.5bn) for Stiefel Laboratories of the US, significantly boosting its presence in dermatology as part of a growing portfolio of...
...Abbott Laboratories is set to buy Advanced Medical Optics, a top provider of cataract and laser eye surgery devices, for $1.4bn, in an attempt to increase its share of the growing global eye care market....
...Laboratory Corp v Metabolite Laboratories involves a system for diagnosing a vitamin deficiency related to heart attacks. But it could affect cases well beyond diagnostic medicine. ?...
...s case, LabCorp v Metabolite Laboratories, involves a patented method of correlating blood homocysteine levels with vitamin deficiencies, relating to heart attacks....
...Ideo also happens to be popular within the technology industry, having designed some of the most notable innovative products: the first laptop personal computer, Apple Computer’s first mouse and the Palm V...
International Edition